Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
Haroun Gajraj, Phlebologist and Board Member of the British Association of Sclerotherapists, shared a post on LinkedIn about a recent article by Gabriel Henrique Simoni et al., published in JVS-VL, adding:
“Cryo-Laser and Cryo- Sclerotherapy
Why is your patient asking about CLaCS before you’ve had the chance to explain it?
A patient walks into your clinic having already watched a video of CLaCS: the vein map projected onto the skin, the laser, the cold air, the injection.
She’s read that it clears leg veins with less bruising and less staining than sclerotherapy. And she wants to know why you are not offering it.
In this clip from my new video, I set up the question I spend the rest of it answering…
What does the first-ever pooled meta-analysis of CLaCS against sclerotherapy alone actually show, and what does it leave out?
The headline figures tell one story.
What the comparison group in the largest trial actually received tells a very different one.
Full breakdown, including the evidence tables and the guideline positions, goes live Wednesday.
Link to the full article and video in the comments on Wednesday 12th August.”
Title: Cryo-Laser Cryo-Sclerotherapy Versus Isolated Sclerotherapy for Telangiectasias and Reticular Veins a Systematic Review and Meta-Analysis
Authors: Gabriel Henrique Simoni, Dario Madera, Nikolaos Papatheodorou, Samantha Neves, Ana Clara Pizarro Varella, Julia Gonçalves Alonso, Nasser Mahfouz
Proceed to the video attached to the post.
Other posts featuring Haroun Gajraj on Hemostasis Today.
-
Sep 29, 2026, 16:18Edward Lee Carter: Why Periprocedural DOAC Guidance Needs a Common Output Standard
-
Sep 29, 2026, 16:07Yasmine Laraba: Deep Vein Thrombosis Causes, Signs and Management
-
Sep 29, 2026, 16:01Stephen Cornelissen: How Joining the Stem Cell Registry Can Save Patients with Blood Cancers
-
Sep 29, 2026, 15:45Alan Nurden: Could Mast Cell aIIb Integrin Play a Key Role in Septic Thrombus Stability?
-
Sep 29, 2026, 15:43Priyadarshani Sharma: Advocacy and Patient Rights Transform Indian Haemoglobinopathies Care
-
Sep 29, 2026, 15:21Kanchan K Banerjee: Rusfertide Earns NCCN Category 1 Recommendation for Polycythemia Vera
-
Sep 29, 2026, 15:06Faizan Khan։ The Worldwide Burden of Venous Thromboembolism
-
Sep 29, 2026, 14:59Global Von Willebrand Disease Diversity Webinar Now Available on EHC YouTube – EHC
-
Sep 29, 2026, 14:43Mary Cushman: Apply to Shape Scientific Publishing as ISTH Associate Editor